Evidence map›Paper›PMID 39170031›Full record

ReviewSichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition2024

[Research Progress in Organocatalysts Used in the Synthesis of Medical Polyurethanes and Their Biotoxicity].

Daiguo Zhao, Mingjie Zhang, Zhen Li, Wanling Lan, Mingjiang Meng, Hong Tan

Abstract readReviewEnglish Abstract
In one paragraph

Review in Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Daiguo Zhao() ( 611731) Sichuan Provincial Institute for Drug Control (Sichuan Medical Device Testing Center), Chengdu 611731, China.
Mingjie Zhang() ( 611731) Sichuan Provincial Institute for Drug Control (Sichuan Medical Device Testing Center), Chengdu 611731, China.
Zhen Li() ( 611731) Sichuan Provincial Institute for Drug Control (Sichuan Medical Device Testing Center), Chengdu 611731, China.
Wanling Lan() ( 611731) Sichuan Provincial Institute for Drug Control (Sichuan Medical Device Testing Center), Chengdu 611731, China.
Mingjiang Meng() ( 611731) Sichuan Provincial Institute for Drug Control (Sichuan Medical Device Testing Center), Chengdu 611731, China.
Hong Tan() ( 611731) Sichuan Provincial Institute for Drug Control (Sichuan Medical Device Testing Center), Chengdu 611731, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Medical polyurethanes have emerged as a leading choice for biomedical applications owing to their exceptional biocompatibility and good physical and mechanical properties. Catalysts play a crucial role as additives in the synthesis of medical polyurethanes, enhancing synthesis efficiency and material properties. However, the catalysts used may affect the biocompatibility of polyurethanes and pose potential harm to human health. This review encapsulates the latest findings regarding the catalysts employed in the synthesis of medical polyurethane materials and their biotoxicity. Initially, we reviewed the prevalent types of catalysts used in the synthesis of medical polyurethane materials and described their distinctive characteristics. Subsequently, our focus shifted to exploring the potential biotoxicity associated with these catalysts. Finally, we provided a forward-looking perspective and recommendations for the future trajectory of catalyst selection in the synthesis of medical polyurethane materials. By acquiring a more profound understanding of the properties and biotoxicity of catalysts used in the synthesis of medical polyurethane materials, and by uncovering existing issues and challenges, we can better guide the design of medical polyurethane materials. This, in turn, enables us to chart the course for future development and ultimately enhance the biocompatibility and safety profiles of medical polyurethane materials. Such advancements will promote the continued development and application of medical polyurethane materials in clinical settings.

Indexed as

Biocompatible MaterialsPolyurethanesCatalysisHumansBiocompatible MaterialsPolyurethanesBiotoxicityCatalystOrganic bismuthOrganotinPolyurethaneResearch progress

Identifiers

PMID39170031
PMCPMC11334272

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.